ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $819,000 | -17.5% | 29,200 | 0.0% | 0.24% | -23.5% |
Q3 2021 | $993,000 | -16.8% | 29,200 | 0.0% | 0.31% | -18.8% |
Q2 2021 | $1,193,000 | +1.4% | 29,200 | 0.0% | 0.38% | -5.4% |
Q1 2021 | $1,176,000 | -31.9% | 29,200 | 0.0% | 0.40% | -34.9% |
Q4 2020 | $1,727,000 | -3.5% | 29,200 | -20.7% | 0.62% | -15.4% |
Q3 2020 | $1,790,000 | -15.9% | 36,800 | -16.4% | 0.74% | -26.4% |
Q2 2020 | $2,129,000 | +42.4% | 44,000 | -18.2% | 1.00% | +23.4% |
Q1 2020 | $1,495,000 | – | 53,800 | – | 0.81% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |